The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder
- PMID: 37901365
- PMCID: PMC10601929
- DOI: 10.1159/000533523
The Case for the Patient-Centric Development of Novel Digital Sleep Assessment Tools in Major Depressive Disorder
Abstract
Background: Depression imposes a major burden on public health as the leading cause of disability worldwide. Sleep disturbance is a core symptom of depression that affects the vast majority of patients. Nonetheless, it is frequently not resolved by depression treatment and may even be worsened through some pharmaceutical interventions. Disturbed sleep negatively impact patients' quality of life, and persistent sleep disturbance increases the risk of recurrence, relapse, and even suicide. However, the development of novel treatments that might improve sleep problems is hindered by the lack of reliable low-burden objective measures that can adequately assess disturbed sleep in this population.
Summary: Developing improved digital measurement tools that are fit for use in clinical trials for major depressive disorder could promote the inclusion of sleep as a focus for treatment, clinical drug development, and research. This perspective piece explores the path toward the development of novel digital measures, reviews the existing evidence on the meaningfulness of sleep in depression, and summarizes existing methods of sleep assessments, including the use of digital health technologies.
Key messages: Our objective was to make a clear call to action and path forward for the qualification of new digital outcome measures which would enable assessment of sleep disturbance as an aspect of health that truly matters to patients, promoting sleep as an important outcome for clinical development, and ultimately ensure that disturbed sleep will not remain the forgotten symptom of depression.
Keywords: Actigraphy; Depression; Digital health; Digital measures; Insomnia; Major depressive disorder; Sleep.
© 2023 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Digital Measures Development: Lessons Learned from an Expert Workshop Addressing Cross-Therapeutic Area Measures of Sleep.Digit Biomark. 2024 Jul 4;8(1):132-139. doi: 10.1159/000539253. eCollection 2024 Jan-Dec. Digit Biomark. 2024. PMID: 39015515 Free PMC article.
-
Protocol for a randomised controlled trial evaluating the effect of a CBT-I smartphone application (Sleep Ninja®) on insomnia symptoms in children.BMC Psychiatry. 2023 Sep 20;23(1):684. doi: 10.1186/s12888-023-05185-x. BMC Psychiatry. 2023. PMID: 37730577 Free PMC article.
-
Novel Augmentation Strategies in Major Depression.Dan Med J. 2017 Apr;64(4):B5338. Dan Med J. 2017. PMID: 28385173 Review.
-
Sleep disorders as core symptoms of depression.Dialogues Clin Neurosci. 2008;10(3):329-36. doi: 10.31887/DCNS.2008.10.3/dnutt. Dialogues Clin Neurosci. 2008. PMID: 18979946 Free PMC article. Review.
References
-
- American Psychiatric Association . DSM 5 Diagnostic and statistical manual of mental disorders; 2013. p. 947.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous